evaluate the pharmaceuticals company saxenda on glp-1 and insurance providers drugs have a broad impact patients, providers, economy Does United Healthcare cover Saxenda?

Fan Z, Aman Y, Ahmed I, Chetelat G, Landeau B, Ray Chaudhuri K, et al

patent expiry in 2028 the single biggest loss of exclusivity event on the horizon

Potential causes include undiagnosed medical conditions, medication interactions, or significant lifestyle changes

Cell Metab 23(3):427440

Program retention is one of the biggest challenges GLP-1 users face today between side effects, cost, duration, and the mental health aspects of treatment, many patients stop taking the medication within just months

Some patients and providers may hesitate to advance to higher doses due to side effects, but remaining at lower doses often results in suboptimal weight loss